The six-gate roadmap, Strategy Lock through Phase 2 Enablement, shows that the sequencing discipline built for one IND is what determines whether a company’s development engine can repeat for a second and third program.
White Paper
From IND to Phase 2: The 24 Months That Determine Whether Your Development Platform Scales
Related Resources
All Resources
post
Why Regulatory Affairs is Important in Drug Approval
Read More
post
What is a Regulatory Affairs Project Manager?
Read More
post
Navigating Regulatory Affairs for Clinical Trials
Read More
webinar
Don’t Derail Drug Development: Common Issues to Identify and Avoid with a First-Rate Quality Process
Read More
Let's move from science to success.
Let’s Talk